AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$AGL

agilon health (NYSE:AGL) delivers impressive Q3 2026, full-year outlook slightly exceeds expectations

Agilon Health (NYSE:AGL) reported Q3 2026 revenue of $1.52 billion, beating estimates by 4.2%. EPS and EBITDA also exceeded expectations. The company raised full-year revenue guidance to $5.88 billion and EBITDA guidance to $150 million. Operating margin improved to 1.6%, and customer count increased to 566,000.

Original reporting
finance.yahoo.com
Published Nov 4, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 9:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
agilon health (NYSE:AGL) delivers impressive Q3 2026, full-year outlook slightly exceeds expectations — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$AGLBullishHigh
01

Why it matters

The earnings beat and guidance raise suggest improved operational performance and may attract new capital.

02

Market read

First report of Q3 2026 earnings with a beat and raised guidance, offering a clear trading catalyst.

03

What to watch

Potential headwinds from payer reimbursement rates or regulatory changes not discussed in the release.

Relevance 8/10Novelty 8/10Timing: post-market release

Background

Agilon Health is a provider of value-based care services to health plans and employers.

Company-level read

Ticker impact

$AGLBullishHigh confidence
Context

Agilon Health reported Q3 2026 results beating revenue and EPS estimates and raised full-year revenue guidance.

Expected impact

likely upward pressure as investors price in better-than-expected performance and higher guidance

Evidence & confidence

Revenue beat, EPS beat, and guidance lift are fresh, material data that typically drive price gains.

Market effects

Sector

Positive signal for the healthcare services sector, may lift peers with similar business models.

Regional

U.S. healthcare market may see modest uplift.

Global

Limited to U.S. markets; no direct global impact.

Counterpoint

What could challenge this read

If the guidance lift is modest relative to expectations, the stock could face profit-taking.

Key entities

  • Company
    Agilon Health

    U.S.-listed healthcare services firm (NYSE:AGL).

Read at source← All news

StoryAgilon Health reports Q3 2026 beat and raises full‑year revenue and EBITDA guidance

Also covered by

2 outlets

Related articles

$AGLMed

Agilon Health Inc (AGL) (Q3 2026) Earnings Call Highlights: Guidance Raised as Adjusted

Agilon Health Inc (AGL) reported Q3 2026 earnings, beating guidance with adjusted EBITDA of $64M, up from -$91M in Q3 2025. The company raised full-year 2026 guidance and expects 40-50% ACO membership growth in 2027. However, Medicare Advantage membership declined 10% YoY, and medical costs remain high. The company plans to expand into new markets starting in 2028. AGL ended Q3 with $312M in cash and raised its year-end cash outlook to at least $175M.

finance.yahoo.com
$AGLMed

Agilon Health Q3 Earnings Call Highlights

Agilon Health (NYSE: AGL) reported a medical services expense ratio of 88.5% in Q3, down from 104% a year earlier. The company exceeded adjusted EBITDA guidance by $64M, citing favorable risk adjustments and cost trends. Agilon raised its full-year cash outlook to at least $175M and expects 40-50% ACO membership growth in 2027. CEO Tim O'Rourke highlighted clinical program expansions and plans for new market partnerships.

finance.yahoo.com
$AGLHighAI 8/10

Agilon: Q3 Earnings Snapshot

Agilon Health Inc. (AGL) reported Q3 net income of $34.9M, or $1.97 per share, beating analyst expectations of a loss. Revenue was $1.52B, also exceeding forecasts. The company expects full-year revenue between $5.87B and $5.89B. Shares have increased fivefold in the past year, closing at $95.76 on Wednesday.

finance.yahoo.com
$AGLMed

agilon health, inc. (AGL): Revenue increased 6% to $1.52 billion Compared to the Same Period in the Prior Year Increases Full Year 2026 Guidance to Reflect Positive Third Quarter Results

agilon health, inc. (AGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 agilon health Reports Third Quarter 2026 Results Revenue increased 6% to $1.52 billion Compared to the Same Period in the Prior Year Increases Full Year 2026 Guidance to Reflect Positive Third Quarter Results Westerville, O.H., November 4, 2026 – agilon health, inc.

SEC EDGAR 8-K